Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Signs MOU to Mine High Grade Zone 2 at Cam Copper Mine (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Northwest Biotherapeutics Inc NWBO

Healthcare Biotechnology
Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing personalized immune therapies for cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The Company's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCQB:NWBO)

Northwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews Strong Progress and Growth Opportunities

PR Newswire July 3, 2024

Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property

PR Newswire June 17, 2024

Northwest Biotherapeutics Appoints Seasoned Business Executive and Investor To Its Board of Directors

PR Newswire March 21, 2024

Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification

PR Newswire February 6, 2024

Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma

PR Newswire December 21, 2023

Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application

PR Newswire November 22, 2023

Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application

PR Newswire October 13, 2023

Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory Board

PR Newswire September 12, 2023

Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans for Submission of Marketing Authorization Application

PR Newswire August 29, 2023
View More News ››

Opinion & Analysis (OTCQB:NWBO)

Danger ahead for Dendreon (DNDN)?

Louis Basenese July 15, 2010
View More Opinion ››

Bullboard Posts (OTCQB:NWBO)

Northwest Biotherapeutics Announces Positive Votes At Annual

JUST IN: $NWBO Northwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews Strong Progress and Growth...
whytestocks - July 3, 2024

RE:RE:2 MASSIVE DATES FOR $NWBO NEXT WEEK.

SusanBolland - January 13, 2022

RE:2 MASSIVE DATES FOR $NWBO NEXT WEEK.

SusanBolland - January 9, 2022

2 MASSIVE DATES FOR $NWBO NEXT WEEK.

NBWO UPDATE
AlphaStatus - November 8, 2020

Stock Collaspe

At .38 cents a share the company is in big trouble No FDA approval and even if they have a cure for cancer the FDA will not approve the...
mepecachew - September 18, 2016

Bought some today!

I'm still very unhappy with the hold on enrollment and it's taking way to long to resolve! But everything has a price and below...
pericles1 - January 14, 2016
View more Bullboard ››

Fobi AI Inc

Fobi AI Inc

Fobi AI Inc. is a Canada-based artificial intelligence (AI) and data intelligence company. The Company operates in the ...
View More »
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested